These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15121136)

  • 1. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch.
    Albani F; Grassi B; Ferrara R; Turrini R; Baruzzi A;
    Seizure; 2004 Jun; 13(4):254-63. PubMed ID: 15121136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre observational study evaluating immediate and progressive switching from carbamazepine to oxcarbazepine in patients with epilepsy.
    Albani F; Bisulli F; Bartezaghi M; Turrini R; Baruzzi A;
    Funct Neurol; 2007; 22(2):111-5. PubMed ID: 17637215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
    Albani F; Baruzzi A;
    Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
    Pauletto G; Bergonzi P;
    Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
    Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
    Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy.
    Sachdeo RC; Gates JR; Bazil CW; Barkley GL; Tatum W; D'Souza J; McCague K
    Epilepsy Behav; 2006 Nov; 9(3):457-63. PubMed ID: 16934534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures.
    Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP;
    Seizure; 2007 Dec; 16(8):670-9. PubMed ID: 17574448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
    Lee WC; Hoffmann MS; Arcona S; D'Souza J; Wang Q; Pashos CL
    Clin Ther; 2005 Oct; 27(10):1629-38. PubMed ID: 16330300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lamotrigine and oxcarbazepine monotherapy for pediatric focal epilepsy: An observational study.
    Hur YJ
    Seizure; 2018 Aug; 60():123-126. PubMed ID: 29957441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures.
    Schachter SC; Vazquez B; Fisher RS; Laxer KD; Montouris GD; Combs-Cantrell DT; Faught E; Willmore LJ; Morris GL; Ojemann L; Bennett D; Mesenbrink P; D'Souza J; Kramer L
    Neurology; 1999 Mar; 52(4):732-7. PubMed ID: 10078718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia.
    Gomez-Arguelles JM; Dorado R; Sepulveda JM; Herrera A; Arrojo FG; Aragón E; Huete CR; Terrón C; Anciones B
    J Clin Neurosci; 2008 May; 15(5):516-9. PubMed ID: 18378142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine: new preparation. An alternative to carbamazepine in partial epilepsy.
    Prescrire Int; 2001 Dec; 10(56):170-4. PubMed ID: 11824439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
    Homberg V; Kowalik A; Schulze-Bonhage A
    Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.